about
The effect of plasmapheresis on blood pressure in voluntary plasma donorsProteomics: applications in transfusion medicine.Prospective multicentre study of the effect of voluntary plasmapheresis on plasma cholesterol levels in donors.Therapeutic plasma proteins--application of proteomics in process optimization, validation, and analysis of the final product.A comparative study of the effects of temperature, time and factor VIII assay type on factor VIII activity in cryoprecipitate in Iran.Factors affecting the quality of cryoprecipitateRedox Status, Procoagulant Activity, and Metabolome of Fresh Frozen Plasma in Glucose 6-Phosphate Dehydrogenase Deficiency.
P2860
Q34999530-BD0EEF9F-9B85-4CE2-92B1-FAE3FC669236Q37062388-2DDA1855-C494-4A14-BC8E-60EA33E82073Q37270109-10F5290E-A5B4-4832-B357-15E9179B264FQ37872258-59D06B49-416B-4981-8D79-1CC3E73089F6Q38809730-022E771E-7D61-4810-936A-D60D3A878501Q42143028-C82DE2E0-9C56-4EC5-A306-BBA3BC682B6DQ49828884-F0A10361-EA74-47E5-8932-9B8F5AF8F014
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Plasma for fractionation: safety and quality issues.
@ast
Plasma for fractionation: safety and quality issues.
@en
type
label
Plasma for fractionation: safety and quality issues.
@ast
Plasma for fractionation: safety and quality issues.
@en
prefLabel
Plasma for fractionation: safety and quality issues.
@ast
Plasma for fractionation: safety and quality issues.
@en
P2860
P1433
P1476
Plasma for fractionation: safety and quality issues.
@en
P2093
Farrugia A
P2860
P304
P356
10.1111/J.1365-2516.2004.00911.X
P577
2004-07-01T00:00:00Z